Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mirtazapine vs gabapentin for uremic pruritus in chronic kidney disease
IRCT20150629022965N20Phase 3Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of mirtazapine and gabapentin in chronic kidney disease-associated pruritus (CKD-aP) and chronic kidney disease (CKD) (2 arms), sponsored by Hamadan University of Medical Sciences. Started Apr 2018; status: completed.
02
Drugs
mirtazapinegabapentin
03
Conditions
chronic kidney disease-associated pruritus (CKD-aP)chronic kidney disease (CKD)
Beyond the preview
Go deeper on IRCT20150629022965N20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20150629022965N20.